US Patent Issued to MIRATI THERAPEUTICS on Nov. 11 for "Crystalline form of a multi-tyrosine kinase inhibitor, method of preparation, and use thereof" (Canadian Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,838, issued on Nov. 11, was assigned to MIRATI THERAPEUTICS INC. (Princeton, N.J.).

"Crystalline form of a multi-tyrosine kinase inhibitor, method of preparation, and use thereof" was invented by Franck Raeppel (Montreal) and Stephane L. Raeppel (Boucherville, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to crystalline forms of N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (Compound 1), pharmaceutical compositions comprising the crystalline form, processes for preparing the crystalline form and methods of u...